{"id":"desogestrel-ethinyl-estradiol-21-tablets","safety":{"commonSideEffects":[{"rate":"10-15","effect":"Nausea"},{"rate":"5-10","effect":"Headache"},{"rate":"5-10","effect":"Breast tenderness"},{"rate":"5-15","effect":"Breakthrough bleeding"},{"rate":"5","effect":"Mood changes"},{"rate":"0.3-0.4","effect":"Venous thromboembolism"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This combination oral contraceptive contains a progestin (desogestrel) and an estrogen (ethinyl estradiol) that work synergistically to inhibit gonadotropin-releasing hormone and suppress follicle-stimulating hormone and luteinizing hormone secretion. By preventing the LH surge, ovulation is blocked, and the progestin also thickens cervical mucus and alters the endometrium to provide additional contraceptive efficacy.","oneSentence":"Desogestrel-ethinyl estradiol prevents ovulation by suppressing the luteinizing hormone surge through progestin and estrogen feedback on the hypothalamic-pituitary axis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:09:08.123Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception / prevention of pregnancy"}]},"trialDetails":[{"nctId":"NCT05002738","phase":"PHASE4","title":"Desogestrel-containing COCP Pharmacokinetic Validation Study","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2021-09-10","conditions":"Contraception","enrollment":22},{"nctId":"NCT02367846","phase":"PHASE4","title":"Assessing the Impact of Contraceptives on Bone Health Using 41Ca","status":"ACTIVE_NOT_RECRUITING","sponsor":"Penn State University","startDate":"2015-01","conditions":"Other Disorders of Bone Development and Growth","enrollment":6},{"nctId":"NCT05594186","phase":"NA","title":"Nonsurgical Management of Cesarean Scar Niche Related Abnormal Uterine Bleeding","status":"COMPLETED","sponsor":"Saudi German Hospital - Madinah","startDate":"2019-03-01","conditions":"Intermenstrual Bleeding","enrollment":158},{"nctId":"NCT00778999","phase":"PHASE4","title":"Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-10-01","conditions":"Infertility","enrollment":442},{"nctId":"NCT00544882","phase":"PHASE3","title":"A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2007-10-31","conditions":"Healthy","enrollment":61},{"nctId":"NCT01638767","phase":"PHASE4","title":"NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization Cycles","status":"TERMINATED","sponsor":"Clinique Ovo","startDate":"2012-07","conditions":"Infertility","enrollment":7},{"nctId":"NCT01252186","phase":"PHASE2","title":"A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women","status":"COMPLETED","sponsor":"Teva Women's Health","startDate":"2010-11","conditions":"Hemostasis, Oral Contraceptive","enrollment":265},{"nctId":"NCT01076582","phase":"PHASE3","title":"Comparative Trial in Hormone Withdrawal Associated Symptoms","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-04","conditions":"Oral Contraceptive","enrollment":592},{"nctId":"NCT01466673","phase":"PHASE4","title":"An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment","status":"COMPLETED","sponsor":"Janssen-Cilag Ltd.,Thailand","startDate":"2008-12","conditions":"Acne Vulgaris","enrollment":201},{"nctId":"NCT00326404","phase":"PHASE3","title":"Continuous Versus Cyclic Use of Oral Contraceptive Pills in Adolescents","status":"UNKNOWN","sponsor":"The Hospital for Sick Children","startDate":"2006-05","conditions":"Contraception","enrollment":130},{"nctId":"NCT00675779","phase":"NA","title":"Efficacy Study of Atorvastatin in Pelvic Pain Relief in Women With Endometriosis","status":"UNKNOWN","sponsor":"Poznan University of Medical Sciences","startDate":"2008-04","conditions":"Endometriosis, Pain","enrollment":44}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Marvelon-21"],"phase":"phase_3","status":"active","brandName":"Desogestrel-Ethinyl Estradiol 21 tablets","genericName":"Desogestrel-Ethinyl Estradiol 21 tablets","companyName":"The Hospital for Sick Children","companyId":"the-hospital-for-sick-children","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Desogestrel-ethinyl estradiol prevents ovulation by suppressing the luteinizing hormone surge through progestin and estrogen feedback on the hypothalamic-pituitary axis. Used for Contraception / prevention of pregnancy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}